ipamorelin fda status or approval BPC-157 Legal Status: Regulations and Compounding FDA Peptide Reclassification 2026: What

10.5935/1518-0557.20240073 14 ChowdhuryM

10.3389/fnins.2023.1148258 Summary Keywords Sijunzi decoction, Parkinsons disease, molecular docking, network pharmacology, molecular dynamics simulation Citation Jiang Y, Wu W, Xie L, Zhou Y, Yang K, Wu D, Xu W, Fang R and Ge J (2024) Molecular targets and mechanisms of Sijunzi decoction in the treatment of Parkinsons disease: evidence from network pharmacology, molecular docking, molecular dynamics simulation, and experimental validation

PMID 25250037

Poor attribution skills should also make us skeptical

A special acknowledgement goes to my therapist, Durea, who was always meticulous when working on my skin

Artificial intelligence in ophthalmology: accuracy, challenges, and clinical application